• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 3T 磁共振成像和磁共振引导活检中通过扩散加权成像对前列腺炎和前列腺癌进行鉴别诊断。

Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.

机构信息

Department of Technical Medicine, University of Twente, Enschede, The Netherlands.

出版信息

Radiology. 2013 Apr;267(1):164-72. doi: 10.1148/radiol.12111683. Epub 2013 Jan 17.

DOI:10.1148/radiol.12111683
PMID:23329653
Abstract

PURPOSE

To determine if prostatitis and prostate cancer (PCa) can be distinguished by using apparent diffusion coefficients (ADCs) on magnetic resonance (MR) images, with specimens obtained at MR-guided biopsy as the standard of reference.

MATERIALS AND METHODS

The need for institutional review board approval and informed consent was waived. MR-guided biopsies were performed in 130 consecutive patients with cancer-suspicious regions (CSRs) on multiparametric MR images obtained at 3 T. In this retrospective study, 88 patients met the inclusion criteria. During the biopsy procedure, an axial diffusion-weighted sequence was performed and ADC maps were generated (repetition time msec/echo time msec, 2000/67; section thickness, 4 mm; in-plane resolution, 1.8 × 1.8 mm; and b values of 0, 100, 500, and 800 sec/mm(2)). Subsequently, a confirmation image with the needle left in situ was acquired and projected on the ADC map. The corresponding ADCs at the biopsy location were compared with the histopathologic outcomes of the biopsy specimens. Linear mixed-model regression analyses were used to test for ADC differences between the histopathologic groups.

RESULTS

The study included 116 biopsy specimens. Median ADCs of normal prostate tissue, prostatitis, low-grade PCa (Gleason grade components 2 or 3), and high-grade PCa (Gleason grade components 4 or 5) were 1.22 × 10(-3) mm(2)/sec (standard deviation, ± 0.21), 1.08 × 10(-3) mm(2)/sec (± 0.18), 0.88 × 10(-3) mm(2)/sec (± 0.15), and 0.88 × 10(-3) mm(2)/sec (± 0.13), respectively. Although the median ADCs of biopsy specimens with prostatitis were significantly higher compared with low- and high-grade PCa (P < .001), there is a considerable overlap between the tissue types.

CONCLUSION

Diffusion-weighted imaging is a noninvasive technique that shows differences between prostatitis and PCa in both the peripheral zone and central gland, although its usability in clinical practice is limited as a result of significant overlap in ADCs.

摘要

目的

通过磁共振(MR)图像上的表观扩散系数(ADC)来确定前列腺炎和前列腺癌(PCa)是否可以区分,以 MR 引导活检的标本作为参考标准。

材料与方法

本研究获得了机构审查委员会的批准豁免和知情同意。在 3T 多参数 MR 图像上获得癌症可疑区域(CSR)的 130 例连续患者进行了 MR 引导活检。在这项回顾性研究中,88 例患者符合纳入标准。在活检过程中,进行了轴向扩散加权序列并生成 ADC 图(重复时间毫秒/回波时间毫秒,2000/67;层厚 4 毫米;平面分辨率 1.8×1.8 毫米;b 值为 0、100、500 和 800 sec/mm(2))。随后,采集一个带有原位针尖的确认图像并将其投影到 ADC 图上。将活检部位的相应 ADC 与活检标本的组织病理学结果进行比较。使用线性混合模型回归分析来测试组织病理学组之间的 ADC 差异。

结果

研究包括 116 个活检标本。正常前列腺组织、前列腺炎、低级别 PCa(Gleason 分级成分 2 或 3)和高级别 PCa(Gleason 分级成分 4 或 5)的平均 ADC 值分别为 1.22×10(-3)mm(2)/sec(标准差±0.21)、1.08×10(-3)mm(2)/sec(标准差±0.18)、0.88×10(-3)mm(2)/sec(标准差±0.15)和 0.88×10(-3)mm(2)/sec(标准差±0.13)。尽管前列腺炎活检标本的平均 ADC 值明显高于低级别和高级别 PCa(P<.001),但组织类型之间存在相当大的重叠。

结论

扩散加权成像技术是一种非侵入性技术,可显示前列腺炎和 PCa 在周围区和中央腺体之间的差异,尽管由于 ADC 显著重叠,其在临床实践中的可用性受到限制。

相似文献

1
Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.在 3T 磁共振成像和磁共振引导活检中通过扩散加权成像对前列腺炎和前列腺癌进行鉴别诊断。
Radiology. 2013 Apr;267(1):164-72. doi: 10.1148/radiol.12111683. Epub 2013 Jan 17.
2
Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.3.0T MRI 下表观扩散系数与前列腺癌外周带 Gleason 分级的关系。
Radiology. 2011 May;259(2):453-61. doi: 10.1148/radiol.11091409.
3
Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.扩散峰度成像与标准扩散成像在周围区前列腺癌检测及分级中的评估
Invest Radiol. 2015 Aug;50(8):483-9. doi: 10.1097/RLI.0000000000000155.
4
Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience.肾肿块:弥散加权磁共振成像特征分析——初步经验
Radiology. 2008 May;247(2):458-64. doi: 10.1148/radiol.2472070823.
5
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.基于经直肠超声引导下系统穿刺活检中 Gleason 评分≤3+3=6 的患者,应用弥散加权磁共振成像(DWI)识别高级别前列腺癌的初步经验:与根治性前列腺切除术相关的系列研究。
Invest Radiol. 2012 Mar;47(3):153-8. doi: 10.1097/RLI.0b013e31823ea1f0.
6
Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.评价扩散加权磁共振成像在低危前列腺癌主动监测方案中的应用。
Invest Radiol. 2013 Mar;48(3):152-7. doi: 10.1097/RLI.0b013e31827b711e.
7
Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.磁共振弥散加权成像在前列腺移行区:利用磁共振引导活检标本的组织病理学验证。
Invest Radiol. 2013 Oct;48(10):693-701. doi: 10.1097/RLI.0b013e31828eeaf9.
8
Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.前列腺癌:联合扩散加权磁共振成像与三维氢质子磁共振波谱成像的鉴别——与病理结果的相关性
Radiology. 2008 Feb;246(2):480-8. doi: 10.1148/radiol.2462070368.
9
Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.移行区前列腺癌:3T 多参数磁共振成像的检测和定位。
Radiology. 2013 Jan;266(1):207-17. doi: 10.1148/radiol.12120281. Epub 2012 Nov 9.
10
Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.前列腺癌:扩散峰度模型检测和评估外周区癌侵袭性的可行性及初步经验。
Radiology. 2012 Jul;264(1):126-35. doi: 10.1148/radiol.12112290. Epub 2012 May 1.

引用本文的文献

1
Analysis of Inflammatory Features in Suspicious Lesions for Significant Prostate Cancer on Magnetic Resonance Imaging-Are They Mimickers of Prostate Cancer?磁共振成像上可疑显著前列腺癌病变的炎症特征分析——它们是前列腺癌的模仿者吗?
Cancers (Basel). 2024 Dec 27;17(1):53. doi: 10.3390/cancers17010053.
2
Diffuse, Bilateral Prostate Imaging Reporting and Data System (PI-RADS) 3 Changes Reported as Inflammation and Their Relation to Clinically Significant Prostate Cancer: A Retrospective Observational Study.弥漫性双侧前列腺影像报告和数据系统(PI-RADS)3类改变报告为炎症及其与临床意义前列腺癌的关系:一项回顾性观察研究
Cureus. 2024 Dec 4;16(12):e75101. doi: 10.7759/cureus.75101. eCollection 2024 Dec.
3
Magnetic Resonance Elastography Combined With PI-RADS v2.1 for the Identification of Clinically Significant Prostate Cancer.
磁共振弹性成像结合PI-RADS v2.1用于识别具有临床意义的前列腺癌。
J Magn Reson Imaging. 2025 May;61(5):2248-2257. doi: 10.1002/jmri.29653. Epub 2024 Nov 8.
4
Improved diagnostic accuracy of readout-segmented echo-planar imaging for peripheral zone clinically significant prostate cancer: a retrospective 3T MRI study.基于读出分段回波平面成像的外周带临床显著前列腺癌诊断准确性的改善:一项回顾性 3T MRI 研究。
Sci Rep. 2024 Feb 8;14(1):3299. doi: 10.1038/s41598-024-53898-0.
5
MR fingerprinting of the prostate.前列腺的 MR 成像技术
MAGMA. 2022 Aug;35(4):557-571. doi: 10.1007/s10334-022-01012-8. Epub 2022 Apr 13.
6
A preliminary study on the diagnostic value of PSADR, DPC and TSRP in the distinction of prostatitis and prostate cancer.PSADR、DPC 和 TSRP 在前列腺炎和前列腺癌鉴别诊断中的诊断价值初探。
BMC Cancer. 2022 Mar 31;22(1):348. doi: 10.1186/s12885-022-09445-z.
7
SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.SUVmax/ADC比值作为未经活检的原发性前列腺癌诊断的分子影像生物标志物
Indian J Nucl Med. 2021 Oct-Dec;36(4):377-384. doi: 10.4103/ijnm.ijnm_62_21. Epub 2021 Dec 15.
8
Impact of Chronic Prostatitis on the PI-RADS Score 3: Proposal for the Addition of a Novel Binary Suffix.慢性前列腺炎对前列腺影像报告和数据系统(PI-RADS)3分的影响:关于添加一个新的二元后缀的提议
Diagnostics (Basel). 2021 Mar 30;11(4):623. doi: 10.3390/diagnostics11040623.
9
Assessment of prostate imaging reporting and data system version 2.1 false-positive category 4 and 5 lesions in clinically significant prostate cancer.评估前列腺影像报告和数据系统第 2.1 版的 4 类和 5 类假阳性病变与临床显著前列腺癌的相关性。
Abdom Radiol (NY). 2021 Jul;46(7):3410-3417. doi: 10.1007/s00261-021-03023-w. Epub 2021 Mar 12.
10
Diagnostic Ability of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer and Clinically Significant Prostate Cancer in Equivocal Lesions: A Systematic Review and Meta-Analysis.动态对比增强磁共振成像对可疑病变中前列腺癌及临床显著性前列腺癌的诊断能力:一项系统评价与Meta分析
Front Oncol. 2021 Feb 19;11:620628. doi: 10.3389/fonc.2021.620628. eCollection 2021.